Outdoor enthusiasts hoping to avoid catching a potentially debilitating bacterium from a tick bite could soon have another layer of defense joining bug sprays and long clothing.
New clinical trial data from vaccine makers Pfizer and Valneva show that their Lyme disease shot reduced cases by about 70 percent compared with a placebo, the companies reported March 23 in a press release. If regulatory agencies give the vaccine, dubbed LB6V, the green light, it would help fend off Lyme disease in hikers, gardeners and others at risk for tick bites.
#newsletter-helper svg { width: auto; fill: #f1563e; } #newsletter-helper { display: flex; border-top: 1px solid gray;